NCT05607030: An ongoing trial by Osteal Therapeutics, Inc.
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 5 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05607030 |
|---|---|
| Title | A Second Randomized Controlled Trial of Alternating Irrigation of Vancomycin Hydrochloride and Tobramycin Sulfate in Patients Undergoing Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection of the Hip or Knee |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 23, 2023 |
| Completion date | May 20, 2024 |
| Required reporting date | May 20, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |